Global Plasma Protein Therapeutics Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Plasma Protein Therapeutics Market
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Due to the COVID-19 pandemic, the global Plasma Protein Therapeutics market size is estimated to be worth US$ 30140 million in 2022 and is forecast to a readjusted size of US$ 44730 million by 2028 with a CAGR of 6.8% during the review period. Fully considering the economic change by this health crisis, Coagulation Factor accounting for % of the Plasma Protein Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hemophilia segment is altered to an % CAGR throughout this forecast period.

Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Coagulation Factor

Immune Globulin

Albumin

Others

Segment by Application

Hemophilia

PID

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Plasma Protein Therapeutics market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Shire (Baxalta)

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Kamada

TABLE OF CONTENT

1 Study Coverage
1.1 Plasma Protein Therapeutics Product Introduction

1.2 Market by Type

1.2.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Coagulation Factor

1.2.3 Immune Globulin

1.2.4 Albumin

1.2.5 Others

1.3 Market by Application

1.3.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hemophilia

1.3.3 PID

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Plasma Protein Therapeutics Sales Estimates and Forecasts 2017-2028

2.2 Global Plasma Protein Therapeutics Revenue Estimates and Forecasts 2017-2028

2.3 Global Plasma Protein Therapeutics Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Plasma Protein Therapeutics Sales by Region

2.4.1 Global Plasma Protein Therapeutics Sales by Region (2017-2022)

2.4.2 Global Sales Plasma Protein Therapeutics by Region (2023-2028)

2.5 Global Plasma Protein Therapeutics Revenue by Region

2.5.1 Global Plasma Protein Therapeutics Revenue by Region (2017-2022)

2.5.2 Global Plasma Protein Therapeutics Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Plasma Protein Therapeutics Sales by Manufacturers

3.1.1 Global Top Plasma Protein Therapeutics Manufacturers by Sales (2017-2022)

3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Protein Therapeutics in 2021

3.2 Global Plasma Protein Therapeutics Revenue by Manufacturers

3.2.1 Global Plasma Protein Therapeutics Revenue by Manufacturers (2017-2022)

3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Plasma Protein Therapeutics Revenue in 2021

3.3 Global Plasma Protein Therapeutics Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Plasma Protein Therapeutics Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Plasma Protein Therapeutics Sales by Type

4.1.1 Global Plasma Protein Therapeutics Historical Sales by Type (2017-2022)

4.1.2 Global Plasma Protein Therapeutics Forecasted Sales by Type (2023-2028)

4.1.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)

4.2 Global Plasma Protein Therapeutics Revenue by Type

4.2.1 Global Plasma Protein Therapeutics Historical Revenue by Type (2017-2022)

4.2.2 Global Plasma Protein Therapeutics Forecasted Revenue by Type (2023-2028)

4.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)

4.3 Global Plasma Protein Therapeutics Price by Type

4.3.1 Global Plasma Protein Therapeutics Price by Type (2017-2022)

4.3.2 Global Plasma Protein Therapeutics Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Plasma Protein Therapeutics Sales by Application

5.1.1 Global Plasma Protein Therapeutics Historical Sales by Application (2017-2022)

5.1.2 Global Plasma Protein Therapeutics Forecasted Sales by Application (2023-2028)

5.1.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)

5.2 Global Plasma Protein Therapeutics Revenue by Application

5.2.1 Global Plasma Protein Therapeutics Historical Revenue by Application (2017-2022)

5.2.2 Global Plasma Protein Therapeutics Forecasted Revenue by Application (2023-2028)

5.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)

5.3 Global Plasma Protein Therapeutics Price by Application

5.3.1 Global Plasma Protein Therapeutics Price by Application (2017-2022)

5.3.2 Global Plasma Protein Therapeutics Price Forecast by Application (2023-2028)

6 North America

6.1 North America Plasma Protein Therapeutics Market Size by Type

6.1.1 North America Plasma Protein Therapeutics Sales by Type (2017-2028)

6.1.2 North America Plasma Protein Therapeutics Revenue by Type (2017-2028)

6.2 North America Plasma Protein Therapeutics Market Size by Application

6.2.1 North America Plasma Protein Therapeutics Sales by Application (2017-2028)

6.2.2 North America Plasma Protein Therapeutics Revenue by Application (2017-2028)

6.3 North America Plasma Protein Therapeutics Market Size by Country

6.3.1 North America Plasma Protein Therapeutics Sales by Country (2017-2028)

6.3.2 North America Plasma Protein Therapeutics Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Plasma Protein Therapeutics Market Size by Type

7.1.1 Europe Plasma Protein Therapeutics Sales by Type (2017-2028)

7.1.2 Europe Plasma Protein Therapeutics Revenue by Type (2017-2028)

7.2 Europe Plasma Protein Therapeutics Market Size by Application

7.2.1 Europe Plasma Protein Therapeutics Sales by Application (2017-2028)

7.2.2 Europe Plasma Protein Therapeutics Revenue by Application (2017-2028)

7.3 Europe Plasma Protein Therapeutics Market Size by Country

7.3.1 Europe Plasma Protein Therapeutics Sales by Country (2017-2028)

7.3.2 Europe Plasma Protein Therapeutics Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Plasma Protein Therapeutics Market Size by Type

8.1.1 Asia Pacific Plasma Protein Therapeutics Sales by Type (2017-2028)

8.1.2 Asia Pacific Plasma Protein Therapeutics Revenue by Type (2017-2028)

8.2 Asia Pacific Plasma Protein Therapeutics Market Size by Application

8.2.1 Asia Pacific Plasma Protein Therapeutics Sales by Application (2017-2028)

8.2.2 Asia Pacific Plasma Protein Therapeutics Revenue by Application (2017-2028)

8.3 Asia Pacific Plasma Protein Therapeutics Market Size by Region

8.3.1 Asia Pacific Plasma Protein Therapeutics Sales by Region (2017-2028)

8.3.2 Asia Pacific Plasma Protein Therapeutics Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Plasma Protein Therapeutics Market Size by Type

9.1.1 Latin America Plasma Protein Therapeutics Sales by Type (2017-2028)

9.1.2 Latin America Plasma Protein Therapeutics Revenue by Type (2017-2028)

9.2 Latin America Plasma Protein Therapeutics Market Size by Application

9.2.1 Latin America Plasma Protein Therapeutics Sales by Application (2017-2028)

9.2.2 Latin America Plasma Protein Therapeutics Revenue by Application (2017-2028)

9.3 Latin America Plasma Protein Therapeutics Market Size by Country

9.3.1 Latin America Plasma Protein Therapeutics Sales by Country (2017-2028)

9.3.2 Latin America Plasma Protein Therapeutics Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Plasma Protein Therapeutics Market Size by Type

10.1.1 Middle East and Africa Plasma Protein Therapeutics Sales by Type (2017-2028)

10.1.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Type (2017-2028)

10.2 Middle East and Africa Plasma Protein Therapeutics Market Size by Application

10.2.1 Middle East and Africa Plasma Protein Therapeutics Sales by Application (2017-2028)

10.2.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Application (2017-2028)

10.3 Middle East and Africa Plasma Protein Therapeutics Market Size by Country

10.3.1 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2017-2028)

10.3.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Shire (Baxalta)

11.1.1 Shire (Baxalta) Corporation Information

11.1.2 Shire (Baxalta) Overview

11.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Shire (Baxalta) Recent Developments

11.2 CSL

11.2.1 CSL Corporation Information

11.2.2 CSL Overview

11.2.3 CSL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 CSL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 CSL Recent Developments

11.3 Grifols

11.3.1 Grifols Corporation Information

11.3.2 Grifols Overview

11.3.3 Grifols Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Grifols Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Grifols Recent Developments

11.4 Octapharma

11.4.1 Octapharma Corporation Information

11.4.2 Octapharma Overview

11.4.3 Octapharma Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Octapharma Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Octapharma Recent Developments

11.5 Kedrion

11.5.1 Kedrion Corporation Information

11.5.2 Kedrion Overview

11.5.3 Kedrion Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Kedrion Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Kedrion Recent Developments

11.6 LFB Group

11.6.1 LFB Group Corporation Information

11.6.2 LFB Group Overview

11.6.3 LFB Group Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 LFB Group Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 LFB Group Recent Developments

11.7 Biotest

11.7.1 Biotest Corporation Information

11.7.2 Biotest Overview

11.7.3 Biotest Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Biotest Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Biotest Recent Developments

11.8 BPL

11.8.1 BPL Corporation Information

11.8.2 BPL Overview

11.8.3 BPL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 BPL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 BPL Recent Developments

11.9 RAAS

11.9.1 RAAS Corporation Information

11.9.2 RAAS Overview

11.9.3 RAAS Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 RAAS Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 RAAS Recent Developments

11.10 CBPO

11.10.1 CBPO Corporation Information

11.10.2 CBPO Overview

11.10.3 CBPO Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 CBPO Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 CBPO Recent Developments

11.11 Hualan Bio

11.11.1 Hualan Bio Corporation Information

11.11.2 Hualan Bio Overview

11.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 Hualan Bio Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Hualan Bio Recent Developments

11.12 Kamada

11.12.1 Kamada Corporation Information

11.12.2 Kamada Overview

11.12.3 Kamada Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Kamada Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Kamada Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Plasma Protein Therapeutics Industry Chain Analysis

12.2 Plasma Protein Therapeutics Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Plasma Protein Therapeutics Production Mode & Process

12.4 Plasma Protein Therapeutics Sales and Marketing

12.4.1 Plasma Protein Therapeutics Sales Channels

12.4.2 Plasma Protein Therapeutics Distributors

12.5 Plasma Protein Therapeutics Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Plasma Protein Therapeutics Industry Trends

13.2 Plasma Protein Therapeutics Market Drivers

13.3 Plasma Protein Therapeutics Market Challenges

13.4 Plasma Protein Therapeutics Market Restraints

14 Key Findings in The Global Plasma Protein Therapeutics Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample